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Abstract
Background: Chromosomal instability (CIN), a feature widely shared by cells from solid tumors, is caused by occasional
chromosome missegregations during cell division. Two of the causes of CIN are weakened mitotic checkpoint signaling and
persistent merotelic attachments that result in lagging chromosomes during anaphase.
Principal Findings: Here we identify an autophosphorylation event on Mps1 that is required to prevent these two causes of
CIN. Mps1 is phosphorylated in mitotic cells on at least 7 residues, 4 of which by autophosphorylation. One of these, T676,
resides in the activation loop of the kinase domain and a mutant that cannot be phosphorylated on T676 is less active than
wild-type Mps1 but is not kinase-dead. Strikingly, cells in which endogenous Mps1 was replaced with this mutant are viable
but missegregate chromosomes frequently. Anaphase is initiated in the presence of misaligned and lagging chromosomes,
indicative of a weakened checkpoint and persistent merotelic attachments, respectively.
Conclusions/Significance: We propose that full activity of Mps1 is essential for maintaining chromosomal stability by
allowing resolution of merotelic attachments and to ensure that single kinetochores achieve the strength of checkpoint
signaling sufficient to prevent premature anaphase onset and chromosomal instability. To our knowledge, phosphorylation
of T676 on Mps1 is the first post-translational modification in human cells of which the absence causes checkpoint
weakening and CIN without affecting cell viability.
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Introduction
Aneuploidy is a trait widely observed in tumor cells from all
types [1]. Aneuploidy in these cells is the result of occasional
chromosome missegregations, a phenotype referred to as chro-
mosomal instability or CIN. Various defects in the processes that
control chromosome segregation and subsequent cell division can
cause CIN [2] and these include but are not limited to
tetraploidization, defective mitotic checkpoint function and
unresolved merotelic chromosome attachments [3–5].
The mitotic checkpoint prevents chromosomal instability by
delaying anaphase onset until all chromosomes are correctly
attached to the mitotic spindle. To ensure faithful chromosome
segregation, the mitotic checkpoint has to be sufficiently strong to
delay anaphase when as little as one chromosome is not correctly
attached to the spindle. Weakening of the mitotic checkpoint
promotes aneuploidy and it has been proposed that this can
contribute to tumorigenesis [2,5]. Recent examination of a
number of studies that have investigated mitotic checkpoint
responses in a wide variety of tumor cells indicated that about two-
thirds of those tumors have a reduced capacity to maintain a
mitotic arrest when challenged with spindle poisons [5]. Despite
many investigations, molecular explanations for such checkpoint
weakening have yet to be found. Genes encoding checkpoint
components are very infrequently mutated (reviewed in [2,5]) and,
although reported in some instances, altered expression of
checkpoint proteins or mRNA does not appear to correlate well
with the status of CIN (e.g. [6–8]). It is therefore likely that
checkpoint activity is affected by other means, one of which may
be a change in the level of functionally relevant post-translational
modifications or by misregulated enzymatic activities that are
crucial for checkpoint signaling. Finding the relevant modifications
that contribute to checkpoint signal strength and investigating
their status in chromosomally instable tumor cells might give
important information on how checkpoint signaling may have
become compromised in those tumors.
Faithful chromosome segregations requires all chromosomes to
be bi-oriented, with each sister kinetochore attached to one pole.
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the mitotic checkpoint as they involve lack-of-attachment or lack-
of-tension, and are corrected by the chromosomal passenger
complex of which Aurora B is the effector kinase [9]. Merotelic
attachments, however, escape detection by the mitotic checkpoint.
A chromosome is attached in a merotelic fashion when it is bi-
oriented while one of its kinetochores has attachments to both
poles. This chromosome is therefore attached as well as under
tension. Merotely has been suggested as a frequent cause of CIN in
tumor cells [3,10]. Interestingly, slight inhibition of Aurora B
caused frequent persistent merotelic attachments that resulted in
lagging chromosomes in anaphase and aneuploidy of the resulting
daughter cells [11,12]. Reduced Aurora B activity may therefore
be an important cause of chromosome missegregations and CIN in
tumor cells.
Monopolar spindle 1 (Mps1) is a kinase that is essential for the
mitotic checkpoint as well as for efficient Aurora B activation to
allow attachment-error correction [13–16]. Despite its central role
in ensuring faithful chromosome segregation, little is known about
how Mps1 is activated in mitosis or how Mps1 activity correlates
with chromosomal stability.
Results
Mps1 is hyperphosphorylated during mitosis, coinciding with a
peak in its enzymatic activity [16]. To get insight into the
mechanisms of activation of Mps1, mitotic Mps1 was analyzed for
the presence of phosphorylated residues. To this end, a HeLa cell
line stably expressing low levels of LAP-tagged (Localization and
Affinity Purification [17]) Mps1 was used (Fig. 1A, 1B). LAP-Mps1
was isolated from mitotic cells by tandem affinity purification and
analyzed for phospho-peptides using mass spectrometry. A total of
8 phosphorylated residues were found (Fig. 1C). In agreement with
a recent study [18], one of the identified phospho-residues, T676,
is located in the activation (T)-loop of the kinase domain (Fig. 1D).
Another potential T-loop phosphorylation on T686 was identified,
but confidence of assignment to this site was quite low (see more
on this below). Similar identification of phosphorylation sites on in
vitro auto-phosphorylated recombinant GST-Mps1 purified from
insect cells (see Fig. S1A) revealed that three additional residues
were in vitro phosphorylated, and that five of the residues found
phosphorylated in vivo, including T686, were the result of auto-
phosphorylation (Fig.1C). In agreement with this, T676 and T686
were recently found phosphorylated on bacterially expressed
recombinant Mps1 [19].
Many protein kinases are activated by phosphorylation on T-
loop residues [20]. Since both T676 and T686 were reported
recently to contribute to kinase activity [18,19], we created
Threonine-to-Alanine mutants of these two sites (T676A and
T686A) to study their contribution to mitotic checkpoint signaling,
attachment-error-correction and chromosome segregation. To this
end, endogenous Mps1 was depleted from U2OS cells using
shRNA and replaced with either LAP-tagged wild-type (WT)
Mps1 or the T676A or T686A mutants (for details on this assay,
Figure 1. Mps1 is phoshorylated during mitosis on at least 7 residues. (A, B) A monoclononal Hela cell line stably expressing LAP-tagged
Mps1 (HeLa-LAP-Mps1) was analyzed for expression level of LAP-Mps1 relative to endogenous Mps1 as shown by immunoblot (anti-Mps1) (A) and
localization of LAP-Mps1 (anti-GFP) together with centromeres (ACA) and DNA (DAPI) (B). Scale bar is 5 mm. (C) List of phosphorylation sites identified
by mass spectrometry on LAP-Mps1 isolated from mitotic HeLa-LAP-Mps1 cells (left column, in vivo) or on recombinant Mps1 isolated from insect
cells (middle column, in vitro). Phosphorylation sites on recombinant Mps1 were designated ‘auto-phosphorylations’ when sites were not found on
similarly expressed and isolated recombinant kinase-dead Mps1. (D) Schematic overview of phosphorylated residues on Mps1.
doi:10.1371/journal.pone.0002415.g001
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negative control. Expression levels of the different mutants are
shown in Figure 2A. As expected, depletion of Mps1 prevented
cells from accumulating in mitosis upon nocodazole treatment,
indicative of a dysfunctional mitotic checkpoint, and caused
defects in chromosome alignment. The T686A mutant, like the
D664A mutant, was unable to restore either checkpoint signaling
(Fig. 2B, 2C) or chromosome alignment (Fig. 2D). The position of
this threonine in the kinase domain is very well conserved amongst
kinases. It is thought to play a structural role in organizing the
catalytic region [21], but in certain kinases, phosphorylation of this
site was shown to be necessary for full kinase activity [22]. To
discriminate between whether T686A was non-functional due to
compromised structural integrity of the kinase domain or due to
lack of phosphorylation, a mutant bearing a phospho-mimetic
mutation on this site (Aspartic Acid or Glutamic Acid) was tested.
Neither Mps1-T686D nor -T686E could restore spindle check-
point function (Fig. S1B). Even though it is formally possible that
the D/E substitutions do not mimic phosphorylation on this site,
these data are more consistent with a structural role for T686. In
support of this, we have been unable to detect T686 phosphor-
ylation in tissue culture cells using a phospho-specific antibody,
even though this antibody was able to recognize in vitro
autophosphorylated Mps1 (data not shown).
In contrast to T686A, the T676A mutant restored proper
chromosome alignment (Fig. 2D) to the same extent as wild-type.
This indicated that attachment-error-correction by Aurora B was
not affected, in contrast to cells devoid of Mps1 activity ([14], see
discussion for more details). The T676A mutant also rescued
mitotic checkpoint signaling in cells treated with nocodazole
(Fig. 2B, 2C) to the same extent as wild-type Mps1. Nocodazole
treatment presumably causes maximal mitotic checkpoint signal-
ing due to the fact that all kinetochores are unattached. Therefore,
defects that do not cause complete inactivation of the checkpoint
may not be identified in assays in which nocodazole is used, such
as the experiment in Figure 2B. Since the mitotic checkpoint
evolved to prevent the missegregation of one or a few
chromosomes and therefore requires maximal activity per
kinetochore, the contribution of phosphorylation on T676 was
studied in more detail by following unperturbed mitotic progres-
sion of Mps1-depleted U2OS cells expressing LAP-Mps1-T676A
using fluorescence timelapse microscopy. DNA was visualized by
co-transfecting H2B-EYFP. 48% (312 out of 656) of cells
expressing T676A exited mitosis with one or more lagging and/
or misaligned chromosomes, compared to 18% of controls cells
(Fig. 2E, 2F, Movie S1, S2). Of cells that missegregated
chromosomes, 58% entered anaphase with both misaligned and
lagging chromosomes, while 23% and 19% displayed either
misaligned or lagging chromosomes, respectively (Fig. 2G). This
strongly suggested that cells expressing Mps1-T676A have a
diminished capacity to i) delay anaphase onset when few
chromosomes are unaligned and ii) resolve misattachments that
are not sensed by the mitotic checkpoint. This, in turn, promotes
chromosomal instability.
The relationship between chromosome missegregations and
Mps1 kinase activity was investigated by examining the kinase
activities of the T-loop mutants compared to wild-type and
kinase-dead Mps1. Since Mps1 very efficiently phosphorylates
another molecule of Mps1 (Fig. S1A), kinase activities of LAP-
Mps1 proteins immunoprecipitated from mitotic U2OS cells were
examined by using purified recombinant kinase-dead Mps1 as
substrate. The substrate (His6-Mps1-KD (D664A)) can subse-
quently be separated from the kinase (LAP-Mps1) by virtue of its
faster mobility on gel. The T686A mutant showed background
levels of kinase activity (Fig. 3A, 3B), confirming that this mutant
is kinase-dead [19]. In agreement with the inability of T686D or
T686E to restore spindle checkpoint function, these mutants were
also devoid of kinase activity (data not shown). T676A however,
showed reduced kinase activity, to about 20% compared to the
activity of wild-type Mps1 (Fig. 3A, 3B). Phospho-mimetic
mutations (Aspartic Acid, Fig. 3B; or Glutamic Acid, not shown)
could restore activity to about 50% compared to wild-type. Thus
although activity could not be fully restored by mimicking
phosphorylation on T676, these results indicate that phosphor-
ylation on this site plays an important role in ensuring full Mps1
activation during mitosis. To investigate whether this holds true
in cells, we examined whether phosphorylation of T676 is
induced specifically during mitosis by probing cell lysates with an
antibody recognizing phosphorylated T676 (anti-pT676-Mps1).
Lysates of cells expressing wild-type LAP-Mps1 or a LAP-Mps1-
T676/686AA double point mutant, as well as lysates of cells
depleted of endogenous Mps1 by RNAi were used as control for
antibody specificity. Endogenous Mps1 was not phosphorylated
on T676 in U2OS cells treated with thymidine to block cells in S-
phase, but was highly phosphorylated on T676 in mitosis
(Fig. 3C). Note that the exogenous LAP-Mps1-wild-type was
partially phosphorylated on T676 and supershifted in S-phase
(see lane 2, Fig. 3C), indicating that exogenous Mps1 can be
activated during S-phase. Since activity of LAP-Mps1-WT
immunoprecipitated from asynchronous cells is equal to that
immunoprecipitated from mitotic cells (not shown), activation of
exogenous Mps1 in non-mitotic cells is probably due to
overexpression of the protein that can cause spontaneous auto-
activation in the absence of kinetochores [18]. Probing recom-
binant kinase-dead Mps1 that was in vitro phosphorylated by
wild-type Mps1 with the pT676-Mps1 antibody revealed that
even though T676 was not identified as an autophosphorylation
site by MS analysis (Fig. 1C), T676 is auto-phosphorylated in an
intermolecular manner (Fig. 3D).
Mps1 activity is indispensable for cell viability, but viability is
maintained in CIN tumor cells that have a weakened mitotic
checkpoint [5]. Since cells in which endogenous Mps1 was
replaced with LAP-Mps1-T676A showed a reduction in Mps1
kinase activity and a weakened checkpoint, these cells were tested
for viability in a clonogenic assay. For this, U2OS cells were
transfected with Mps1 shRNA and the indicated LAP-Mps1
mutants, along with pBabe-puro. The cells were then grown in
puromycin for two weeks, to allow analysis of viability of
transfected cells only. As expected [14], LAP-Mps1-KD or -
T686A expressing cells could not grow out to form colonies and
thus proved to be unviable in the long term. Surprisingly, LAP-
Mps1-T676A-expressing cells were able to grow out roughly the
same amount of colonies as cells expressing wild-type LAP-Mps1
(Fig. 4A, 4B). This indicated that replacing endogenous Mps1 with
an Mps1-T676A mutant did not significantly reduce cell viability.
To more rigorously address the behavior of cells expressing LAP-
Mps1-T676A, a cell line was created that is devoid of Mps1 but
stably expresses LAP-Mps1-T676A at levels similar to the
endogenous protein prior to its removal by RNAi (UTRM10-
T676A) (Fig. 4C). These cells have been maintained in culture in
our lab for months without obvious proliferation defects.
Importantly, when imaged live, UTRM10-T676A cells displayed
an increased tendency for chromosome missegregations than a
similar cell line expressing wild-type LAP-Mps1 to endogenous
levels (UTRM10-WT) (Fig. 4C, 4D). Thus, complete depletion
from Mps1 kinase activity results in cell death but residual kinase
activity of about 20 percent keeps cells viable yet induces
chromosomal instability.
CIN by Low Mps1 Activity
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PLoS ONE | www.plosone.org 4 June 2008 | Volume 3 | Issue 6 | e2415Figure 3. Lack of T676 auto-phosphorylation reduces Mps1 kinase activity. (A) Kinase activity of LAP-Mps1 mutants (asterisk (*) indicates
mutations that confer resistance to Mps1 shRNA) extracted from mitotic U2OS cells was examined by in vitro kinase activity towards recombinant
kinase-dead His-Mps1 (D664A). (B) Quantification of (A). Relative values to LAP-Mps1-WT were calculated after subtraction of the background signal
derived from ‘mock’ immunoprecipitations (first lane in Fig. 3A). Average of three experiments (+/2SD). (C) Western blot showing phosphorylation
specifically on T676 in lysates form U2OS cells transfected with the indicated constructs (asterisk (*) indicates mutations that confer resistance to
Mps1 shRNA). (D) Western blot showing in vitro intermolecular auto-phosphorylation on T676. Combinations (as indicated) of recombinant wild-type
GST-Mps1(-WT), kinase-dead GST- and His-Mps1(-KD) were subjected to a in vitro kinase reactions, after which proteins were analyzed for reactivity to
pT676 antibody (green) and Mps1 antibody (red) by immunoblot.
doi:10.1371/journal.pone.0002415.g003
Figure 2. T676 phosphorylation is required for correct chromosome segregation and full checkpoint signaling. (A) Expression levels,
as shown by immunoblot (anti-Mps1), in asynchronously growing cells of LAP-Mps1 mutants (asterisk (*) indicates mutations that confer resistance to
Mps1 shRNA) transiently transfected into U2OS cells. (B) Flow cytometric analysis of the fraction of mitotic cells transfected with Mock or Mps1 shRNA
together with the indicated plasmids (asterisk (*) indicates mutations that confer resistance to Mps1 shRNA), and treated with nocodazole for 18 hrs.
(C) Quantification of (B), average of three experiments (+/2SD). (D) U2OS cells transfected as in 2B were treated for 30 minutes with MG132. Fixed
cells were stained with DAPI and the percentage of cells with all chromosomes aligned to the metaphase plate was determined (n=30 cells). Graph
represents the average of three experiments (+/2SD). (E) Mitotic progression of U2OS cells transfected as in 2B along with H2B-EYFP Mps1 was
followed by live cell imaging. Stills from two representative cells showing anaphase with misaligned/lagging chromosomes (arrows) are shown (see
Movie S1 and Movie S2). Scale bar is 5 mm. (F) Quantification of (E), average of three experiments (+/2SD), n=total amount of cells. (G) Graph
showing the fraction of total missegregations as displayed in 2F with misaligned chromosomes, lagging chromosomes, or both in cells expressing
Mps1-T676A.
doi:10.1371/journal.pone.0002415.g002
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We show here that auto-activation of Mps1 by T676 auto-
phosphorylation is essential for full kinase activity and mainte-
nance of chromosomal stability, but not for cell viability. In two
recent studies, T676 of human Mps1 was identified as an
important phosho-site for the regulation of Mps1 activity
[18,19]. All three studies agree that Mps1 lacking this phosphor-
ylation has strongly reduced but still clearly detectable kinase
activity. Kang et al report that mitotic arrest in response to
nocodazole of cells expressing T676A was reduced 2-fold [18],
whereas we found no such decrease. This may be due to cell type-
dependent differences in sensitivity of the checkpoint to the level of
Mps1 inhibition. A more intriguing explanation, however, is the
possibility that the measure that the authors of that study used to
mark mitotic cells, phosphorylation of histone H3, is inadequate
when analyzing effects of Mps1 inhibition on checkpoint signaling,
as we have recently shown that this phosphorylation is dependent
on Mps1 kinase activity in mitotic cells [14].
Kang et al found 10 phosphorylation sites on Mps1 isolated
from mitotic cells [18]. Our combined data from in vivo and in
vitro phosphorylated Mps1 confirms five of those sites, and these
include T360, S363, S436, T676 and S821. It is unclear why there
is discrepancy between the remaining five sites found in the study
by Kang et al and the five additional sites from our in vivo
analysis. As absence of phosphorylation of a peptide in mass
spectrometric analyses is a poor indicator of lack of phosphory-
lation of that sequence in cells, it is quite possible that Mps1 is
phosphorylated on all reported sites, totaling therefore 15
phosphorylated residues. Analysis of Mps1 using phospho-specific
antibodies or other means, combined with thorough functional
analysis of single point mutants is needed to pinpoint functionally
relevant phosphorylations on Mps1 and distinguish actual in vivo
sites from mass spec artifacts.
Cells in which endogenous Mps1 was replaced with T676A
display increased frequency of chromosome missegregations as
evidenced by an increase in anaphases in the presence of
misaligned and/or lagging chromosomes. It is unclear what causes
chromosomes to lag at anaphase in these cells. Possibly, these
chromosomes are unattached but fail to activate the mitotic
checkpoint due to diminished Mps1 activity. More likely, the
laggers point to an inability to correct merotelic attachments. Such
correction is performed by Aurora B activity, that itself is regulated
by Mps1 [14]. Therefore, lagging chromosomes in T676A cells
may be due to diminished Aurora B activity, resulting in persistent
merotely. We have not, however, observed a detectable reduction
in Aurora B activity, as T676A cells treated with MG132 properly
aligned all chromosomes, suggestive of functional attachment-
error-correction, and since levels of Ser7 phosphorylation of the
Aurora B substrate CENP-A were indistinguishable from control
(data not shown). Consistent with this, treatment of cells with low
concentrations of a specific Aurora B kinase inhibitor did not cause
observable inhibition of Aurora B at the level of substrate
phosphorylation, chromosome alignment or cytokinesis yet
resulted in persistent merotely in a significant fraction of cells
[11]. Therefore, it is likely that a small, virtually undetectable,
Figure 4. T676 phosphorylation is required for maintaining chromosomal stability but not cell viability. (A) U2OS cells were transfected
as in 2B along with pBabe-puro, grown under puromycin selection for two weeks after which surviving colonies were stained. Immunoblot (anti-
Mps1) shows expression levels in lysates taken 3 days after transfection of the different LAP-Mps1 mutants. (B) Quantification of the number of
colonies counted in 4A, average of three experiments (+/2SD). (C) Immunoblot (anti-Mps1) showing expression levels of endogenous Mps1 and LAP-
Mps1 in lysates of U2OS cells, and UTRM10 cells continuously expressing Mps1 shRNA through doxycycline treatment [14] that stably express wild-
type LAP-Mps1 (UTRM10-WT) or LAP-Mps1-T676A (UTRM10-T676A). (D) Graph shows average percentages of UTRM10-T676A and UTRM10-WT cells
that missegregate chromosomes as observed with live cell imaging (as in 2E), (+/2SD), n=total amount of cells.
doi:10.1371/journal.pone.0002415.g004
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T676A underlies the occasional lack of correction of a merotelic
attachment in these cells.
Cells expressing Mps1-T676A arrested potently when treated
with nocodazole but initiated anaphase in the presence of
misaligned chromosomes. Thus, although T676 phosphorylation
is not essential when the combined signals from all kinetochores is
strong, it is needed for amplified checkpoint signaling from one or
a few misaligned chromosomes. This supports the hypothesis that
weakening of the mitotic checkpoint can cause non-lethal
chromosomal instability. The contribution of such checkpoint
weakening to CIN in tumor cells was recently questioned by a
study in which filming of chromosome segregation in CIN tumor
cells did not reveal checkpoint defects but suggested merotely as
the most common way to aneuploidy in these cells [10]. Clearly in
the three cell lines examined in that study, checkpoint signaling
strength was sufficient to delay anaphase onset until all
chromosomes had bioriented. In various other tumor cells,
however, checkpoint strength was found to be diminished [5],
and recent evidence from mouse models indicate that in cases
where such weakening occurs, it can contribute to carcinogenesis
([23–25] and references in [2]). The extent of the contribution of
checkpoint weakening to tumor formation is thus controversial
and conclusions will await examination of chromosome segrega-
tion in large panels of cells from patient tumors. Alternatively,
establishment of good biomarkers for detection of weak checkpoint
signaling, such as antibodies to post-translational modifications
that determine strong vs weak signaling, may facilitate this.
Despite original claims that mutations in components of the
checkpoint machinery could underlie CIN [26], subsequent
extensive mutational analysis of cells from many types of tumors
has not confirmed this as a means to decrease the efficiency of
checkpoint signaling (reviewed in [2]). Similarly, misexpression of
checkpoint components has been observed [2] but it is unclear if
this is the origin of CIN in those cells and there is no apparent
consensus about whether up- or downregulation correlates with
aneuploid status of the cells examined (e.g. [6–8]). For instance,
disruption of the Rb tumor suppressor pathway causes CIN by
upregulating Mad2 whereas inactivation of the REST tumor
suppressor causes CIN by decreasing expression of Mad2 [27,28].
Similarly, mice either overexpressing Mad2 or underexpressing
Mad2 develop cancer, albeit that affected organs, tumor types and
latency periods differ [29,30]. It is thus possible that checkpoint
weakening in tumor samples at the molecular level is caused by
altered activity of checkpoint components or by altered post-
translational modifications that contribute to efficiency of the
mitotic arrest.
The data presented here place Mps1 as a central activity to
prevent chromosomal instability. Reduced Mps1 kinase activity
allows weakened mitotic checkpoint signaling as well as lagging
chromosomes at anaphase, two major defects suggested to
contribute to CIN in tumor cells [5,10]. Phosphorylation of
T676 in Mps1 provides the first specific post-translational
modification in human cells as a cause for this. Many more such
modifications may exist and it will be interesting to examine if any
are affected in CIN tumor cells.
Materials and Methods
Cells
U2OS cells were grown in DMEM with 8% FBS, supplemented
with pen/strep. UTRM10 cells [14] were grown similarly with the
exception that tet-approved FBS was used. UTRM10-676A and -
WT cells were created by transfecting UTRM10 cells (Effectene,
Qiagen) with LAP-Mps1-T676A or -WT and selecting for
survivors by continuous culture in 1 mg?ml
21 doxycycline (Sigma).
Clones were subsequently chosen based on expression of the LAP-
tagged Mps1 protein and absence of endogenous Mps1.
Thymidine (2.5 mM), nocodazole (200 ng?ml
21) and puromycin
(1 mg?ml
21) were all from Sigma.
Plasmids, cloning and transfections
pSuper-mock, pSuper-Mps1, pcDNA3-LAP-Mps1-WT and -
D664A have been described [14]. Point mutations were generated
by site-directed mutagenesis. All sequences were verified by
automated sequencing. Mps1 was depleted from U2OS cells
using shRNA and replaced by RNAi-resistant LAP-Mps1-wild-
type, -kinase-dead (D664A), -T676A, or -T686A, by transfection
with calcium phosphate (for details on this protein replacement
assay see [14]).
Antibodies
pT676-Mps1 antibodies were raised in rabbits using the peptide
CMQPDTpTSVVKDS coupled to KLH as antigen (Eurogentec).
Phospho-specific polyclonal antibody used in this study was affinity
purified using the described peptide after removal of non-phospho-
specific antibodies with an unphosphorylated version of the
peptide. Anti-Mps1-NT was from Upstate Biotechnology, ACA
was from Cotrex Biochem and a2Tubulin was from Sigma. Anti-
GFP was a custom polyclonal antibody.
Identification of mitotic phosphorylation sites
Cells were blocked in mitosis by treatment with nocodazole for
18 hrs and harvested by mitotic shake-off. LAP-Mps1 was isolated
by tandem affinity purification [17] and phosphorylated residues
were identified using mass spectrometry as described [31].
In vitro recombinant kinase assay
Wild-type GST-Mps1 was expressed and purified from High-
Five insect cells using the Life Technologies Bac-to-Bac system.
Recombinant active Mps1 was incubated in kinase buffer (50 mM
Tris pH 7.4, 10 mM MgCl2, 0.5 mM DTT, 40 mM ATP) at 30uC
for 30 minutes. (Auto-)phosphorylated residues were identified
using mass-spectrometry as described [14].
IP kinase assay
U2OS cells transfected with the various LAP-Mps1 alleles were
released from a 24 hours thymidine block into nocodazole for
18 hours, harvested and lysed in 150 mM NaCl, 50 mM Hepes
pH7.5, 5 mM EDTA and 0.1% NP40. LAP-Mps1 was removed
from the lysates with S-protein agarose (Novagen) and tested for
kinase activity towards recombinant kinase-dead His-Mps1
(D664A) in kinase buffer (50 mM Tris pH 7.5, 10 mM MgCl2,
0.5 mM DTT, 40 mM ATP) using [c-32P]-ATP.
Flow cytometry and colony outgrowth
U2OS cells were released from a 24 hours thymidine block into
nocodazole for 18 hours, harvested and fixed in 70% ice-cold
ethanol for 24 hours. Fixed cells were immunostained with anti-
Mpm2 (Upstate Biotechnology) to determine the fraction of
mitotic cells. Flow cytometric analysis of transfected cells was done
based on Spectrin-GFP co-transfection. Colony outgrowth assays
were done essentially as described [32].
Immunofluorescence
Immunostaining experiments were done as described [14]. For
alignment analysis, U2OS cells plated on 15 mm coverslips were
CIN by Low Mps1 Activity
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TM (Thermo
electron corporation) for 20 minutes. Fixed cells were stained with
DAPI and the percentage of cells with all chromosomes aligned to
the metaphase plate was determined using fluorescence microsco-
py [14].
Time-lapse video microscopy
Mps1 was depleted from U2OS cells using shRNA and replaced
with RNAi-insensitive LAP-Mps1-WT or -T676A, and mitotic
progression was followed with live cell imaging as described [14].
DNA was visualized by co-transfecting H2B-EYFP.
Supporting Information
Figure S1 (A) Wild-type GST-Mps1 (WT) cross-phosphorylates
kinase-dead His-Mps1 (KD) in vitro as measured by 32P
incorporation from [o ¨ ˚-32P]-ATP. (B) U2OS cells were transfected
with the indicated constructs (asterisk (*) indicates mutations that
confer resistance to Mps1 shRNA). Cells were treated as in (2B)
and the percentage of mitotic cells was determined as in (2B).
Found at: doi:10.1371/journal.pone.0002415.s001 (0.69 MB TIF)
Movie S1 Mps1 was depleted from U2OS cells using shRNA
and replaced with RNAi-insensitive LAP-Mps1-T676A, and
mitotic progression was followed with live cell imaging as
described [14]. DNA was visualized by co-transfecting H2B-
EYFP.
Found at: doi:10.1371/journal.pone.0002415.s002 (0.07 MB
MOV)
Movie S2 Mps1 was depleted from U2OS cells using shRNA
and replaced with RNAi-insensitive LAP-Mps1-T676A, and
mitotic progression was followed with live cell imaging as
described [14]. DNA was visualized by co-transfecting H2B-
EYFP.
Found at: doi:10.1371/journal.pone.0002415.s003 (0.12 MB
MOV)
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